Established, Scalable & Rapidly-Growing

CritiTech is a well-established and rapidly-growing particle engineering company with international reach that utilizes its particle engineering technologies to help its clients and partners develop and manufacture unique and differentiated drugs and medical devices for the human and animal health markets. CritiTech specializes in optimizing the delivery of challenging drug substances-potent molecules, poorly soluble compounds and biomolecules.

CritiTech Staff

Sam Campbell
Matt McClorey
Michael Baltezor, PhD
Chief Scientific Officer
Jeffrey Morrison
Chief Financial Officer
Larry Dickinson
Chief Commercial Officer
Mark Williams
VP of Technical Operations
Jahna Espinosa
Director of Laboratory Operations
Richard Ramos
Director of Support Services
Joseph Farthing
Manager of Analytical Services and Product Characterization
Jake Sittenauer
Manager Drug Development Services
Leah Claypool
Laboratory Technician
Bala Subramaniam, PhD
Shelby Clark
Jamie Blaylock
Quality Documentation Specialist
John Reynolds
Director Quality Operations